Stockreport

While insiders own 20% of Galectin Therapeutics Inc. (NASDAQ:GALT), individual investors are its largest shareholders with 54% ownership [Yahoo! Finance]

Galectin Therapeutics Inc.  (GALT) 
Last galectin therapeutics inc. earnings: 11/12 08:00 am Check Earnings Report
PDF A total of 25 investors have a majority stake in the company with 44% ownership Insiders have bought recently A look at the shareholders of Galectin Therapeutics In [Read more]